Compugen (CGEN) Earnings Date & Reports

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CGEN is expected to report earnings to fall 25.00% to -5 cents per share on July 31

Q2'25

Est.

$-0.06

Q1'25

Missed

by $0.01

Q4'24

Missed

by $0.09

Q3'24

Beat

by $0.11

Q2'24

Beat

by $0.07

The last earnings report on May 19 showed earnings per share of -7 cents, missing the estimate of -7 cents. With 69.05K shares outstanding, the current market capitalization sits at 147.56M.

View a ticker or compare two or three

Compare

CGEN